HK1033579A1 - Pde iv inhibiting pyridine derivatives - Google Patents

Pde iv inhibiting pyridine derivatives

Info

Publication number
HK1033579A1
HK1033579A1 HK01103462A HK01103462A HK1033579A1 HK 1033579 A1 HK1033579 A1 HK 1033579A1 HK 01103462 A HK01103462 A HK 01103462A HK 01103462 A HK01103462 A HK 01103462A HK 1033579 A1 HK1033579 A1 HK 1033579A1
Authority
HK
Hong Kong
Prior art keywords
pde
pyridine derivatives
inhibiting
inhibiting pyridine
derivatives
Prior art date
Application number
HK01103462A
Other languages
English (en)
Inventor
Eddy Jean Edgard Freyne
Gaston Stanislas Marcell Diels
Maria Enc Matesanz-Ballesteros
Adolfo Diaz-Martinez
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1033579A1 publication Critical patent/HK1033579A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
HK01103462A 1998-04-01 2001-05-19 Pde iv inhibiting pyridine derivatives HK1033579A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201020 1998-04-01
PCT/EP1999/002045 WO1999050262A1 (en) 1998-04-01 1999-03-24 Pde iv inhibiting pyridine derivatives

Publications (1)

Publication Number Publication Date
HK1033579A1 true HK1033579A1 (en) 2001-09-07

Family

ID=8233543

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01103462A HK1033579A1 (en) 1998-04-01 2001-05-19 Pde iv inhibiting pyridine derivatives

Country Status (34)

Country Link
US (1) US6656959B1 (no)
EP (1) EP1068194B1 (no)
JP (1) JP4778612B2 (no)
KR (1) KR100596664B1 (no)
CN (1) CN1172930C (no)
AR (1) AR014972A1 (no)
AT (1) ATE253569T1 (no)
AU (1) AU760771B2 (no)
BG (1) BG64705B1 (no)
BR (1) BR9909326A (no)
CA (1) CA2326045C (no)
CZ (1) CZ298747B6 (no)
DE (1) DE69912590T2 (no)
DK (1) DK1068194T3 (no)
EA (1) EA004207B1 (no)
EE (1) EE04718B1 (no)
ES (1) ES2211061T3 (no)
HK (1) HK1033579A1 (no)
HR (1) HRP20000619B1 (no)
HU (1) HU229412B1 (no)
ID (1) ID27207A (no)
IL (2) IL138745A0 (no)
MY (1) MY124696A (no)
NO (1) NO319531B1 (no)
NZ (1) NZ507022A (no)
PL (1) PL196026B1 (no)
PT (1) PT1068194E (no)
SI (1) SI1068194T1 (no)
SK (1) SK284468B6 (no)
TR (1) TR200002801T2 (no)
TW (1) TWI242558B (no)
UA (1) UA66842C2 (no)
WO (1) WO1999050262A1 (no)
ZA (1) ZA200006190B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6639077B2 (en) 2000-03-23 2003-10-28 Merck Frosst Canada & Co. Tri-aryl-substituted-ethane PDE4 inhibitors
MY123585A (en) 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
DE10130397A1 (de) * 2001-06-23 2003-01-09 Bayer Cropscience Gmbh Herbizide substituierte Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbzide und Pflanzenwachstumsregulatoren
DE10318610A1 (de) * 2003-04-24 2004-11-11 Elbion Ag 7-Azaindole und deren Verwendung als Therapeutika
AP2006003771A0 (en) 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
US7863446B2 (en) 2006-01-19 2011-01-04 Orchid Research Laboratories Limited Heterocycles
US8354434B2 (en) 2006-01-30 2013-01-15 Purdue Pharma L.P. Cyclourea compounds as calcium channel blockers
CA2663984C (en) 2006-10-18 2012-02-21 Pfizer Products Inc. Biaryl ether urea compounds
US8420653B2 (en) 2008-02-01 2013-04-16 Orchid Chemicals & Pharmaceuticals Limited Pyrimidine compounds and their uses
JOP20190060A1 (ar) 2016-09-26 2019-03-26 Chugai Pharmaceutical Co Ltd مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876657A (en) * 1971-06-03 1975-04-08 Ashland Oil Inc Preparation of 1-substituted-2-imidazolidinones
US4600430A (en) 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
DE69430747T2 (de) * 1993-07-28 2003-03-06 Aventis Pharma Ltd., West Malling Verbindungen als pde iv und tnf inhibitoren
GB9401460D0 (en) * 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
WO1996004186A1 (en) * 1994-08-03 1996-02-15 Gics & Vermee, L.P. Ovenable food package
TW375612B (en) * 1995-04-06 1999-12-01 Janssen Pharmaceutica Nv 1,3-dihydro-2H-imidazol-2-one derivatives for the treatment of disease states related to an abnormal enzymatic or catalytic activity of phosphodiesterase type IV, preparation thereof and pharmaceutical composition containing the same
TW332201B (en) * 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
TW424087B (en) * 1995-04-06 2001-03-01 Janssen Pharmaceutica Nv 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives
AU6526896A (en) * 1995-07-22 1997-02-18 Rhone-Poulenc Rorer Limited Substituted aromatic compounds and their pharmaceutical use
IL125034A0 (en) * 1995-12-29 1999-01-26 Smithkline Beecham Corp Vitronectin receptor antagonists
TR199900732T2 (xx) 1996-10-02 1999-08-23 Janssen Pharmaceutica N.V. PDE IV inhibe eden 2-siyanoiminoimidazol t�revleri.

Also Published As

Publication number Publication date
SI1068194T1 (en) 2004-04-30
KR20010040681A (ko) 2001-05-15
BG104718A (en) 2001-04-30
AU3147499A (en) 1999-10-18
KR100596664B1 (ko) 2006-07-06
TR200002801T2 (tr) 2000-12-21
HRP20000619B1 (en) 2004-06-30
JP2002509927A (ja) 2002-04-02
ZA200006190B (en) 2001-10-31
NO20004906D0 (no) 2000-09-29
PL343194A1 (en) 2001-07-30
CA2326045C (en) 2008-12-09
BG64705B1 (bg) 2005-12-30
TWI242558B (en) 2005-11-01
PL196026B1 (pl) 2007-11-30
NO20004906L (no) 2000-11-28
IL138745A0 (en) 2001-10-31
EE200000569A (et) 2002-04-15
EA200001009A1 (ru) 2001-02-26
SK13872000A3 (sk) 2001-11-06
CZ298747B6 (cs) 2008-01-16
DE69912590D1 (de) 2003-12-11
EP1068194B1 (en) 2003-11-05
US6656959B1 (en) 2003-12-02
ATE253569T1 (de) 2003-11-15
CZ20003338A3 (cs) 2001-02-14
JP4778612B2 (ja) 2011-09-21
DK1068194T3 (da) 2004-03-15
HU229412B1 (en) 2013-12-30
IL138745A (en) 2007-06-17
HUP0101239A2 (hu) 2002-05-29
EA004207B1 (ru) 2004-02-26
CN1172930C (zh) 2004-10-27
SK284468B6 (sk) 2005-04-01
CN1295571A (zh) 2001-05-16
PT1068194E (pt) 2004-03-31
NO319531B1 (no) 2005-08-29
EE04718B1 (et) 2006-10-16
WO1999050262A1 (en) 1999-10-07
EP1068194A1 (en) 2001-01-17
ID27207A (id) 2001-03-08
DE69912590T2 (de) 2004-09-16
HRP20000619A2 (en) 2001-10-31
ES2211061T3 (es) 2004-07-01
BR9909326A (pt) 2000-12-12
HUP0101239A3 (en) 2002-09-30
AU760771B2 (en) 2003-05-22
CA2326045A1 (en) 1999-10-07
NZ507022A (en) 2002-06-28
AR014972A1 (es) 2001-04-11
UA66842C2 (uk) 2004-06-15
MY124696A (en) 2006-06-30

Similar Documents

Publication Publication Date Title
HRP20030306A2 (en) Pyridine derivatives with ikb-kinase (ikk-?) inhibiting activity
GB9603723D0 (en) Diphenyl pyridyl derivatives as pde iv inhibitors
IL133904A0 (en) Pyridine derivatives
HK1033317A1 (en) Imidazo pyridine derivatives which inhibit gastricacid secretion
PL336148A1 (en) Nicotinamide derivatives
HK1064670A1 (en) Pyridine-3-carboxylic acid derivatives
HK1041480A1 (zh) 喹啉衍生物
IL138160A0 (en) Quinoline derivatives
HK1035715A1 (en) Quinoline derivatives
HK1035716A1 (en) Quinoline derivatives
IL129298A0 (en) PDE iv inhibiting 2-cyanoiminoimidazole derivatives
HK1046400A1 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives
ZA978809B (en) PDE IV inhibiting 2-cyanoiminoimidazole derivatives
IL138745A0 (en) Pde iv inhibiting pyridine derivatives
HK1045698A1 (zh) 阿維菌素衍生物
HU9902270D0 (en) Acridin derivatives
EP1240156A4 (en) 3-METHYL CHROME OR THIOCHROME DERIVATIVES
GB2323842A8 (en) Pyridine derivatives
ZA986137B (en) Pyridine derivatives
GB9809351D0 (en) Heterocyclic derivatives
GB9812410D0 (en) Heterocyclic derivatives

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20190323